Anlon Healthcare Limited (AHCL.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹24.41 (-1.17%) as of
Key statistics
- Market cap
- 12.97B
- P/E (TTM)
- 35.90
- EPS (TTM)
- 0.68
- Dividend yield
- 0.00%
- 52-week range
- 10.37 – 37.24
- Revenue (TTM)
- 2.26B
- Profit margin
- 13.98%
- Volume
- 3.14M
About Anlon Healthcare Limited
Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Rajkot, India
- Employees
- 119
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.